Fair Medicine Prices and Enhancing Pharmaceutical Affordability: Pharmaceutical Pricing
Deadline 2026-11-30Taylor & FrancisIndexed (Active)
Journal: Journal of Pharmaceutical Policy and Practice
Access to medicines is a fundamental human right and medicines pricing is a key determining factor. It is important to note that the countries with a fair pricing mechanism have generated relatively lower prices in international terms for their patients and citizens. The evidence from Low- and Middle-Income Countries (LMICs) suggests that limited price regulation can lead to higher prices. High medicine pricing is a…
Advances in Genomics and Its Healthcare Applications
Deadline 2026-12-31Taylor & FrancisIndexed (Active)
Journal: Journal of Pharmaceutical Policy and Practice
This collection aims to highlight recent progress and emerging trends in genomics applications. It will cover a broad range of subtopics, including but not limited to genomic diagnostics, personalised and precision medicine, pharmacogenomics, cancer genomics, rare genetic diseases, gene therapy, and ethical, legal, and social implications of genomic data use. Genomics is advancing rapidly, shaping research and healt…
Clinical Pharmacy Practice and Policy Research in High-Income Economies: Evidence, Impact, Implementation, and the Way Forward
Deadline 2027-05-31Taylor & FrancisIndexed (Active)
Journal: Journal of Pharmaceutical Policy and Practice
In high-income economies, pharmacy practice plays a pivotal role in optimizing medication use and improving patient outcomes. Pharmacists routinely conduct comprehensive medication reviews, manage chronic diseases, and provide specialized care in both community and hospital settings. As integral members of multidisciplinary healthcare teams, pharmacists are increasingly recognized for their expertise, with strong em…
Clinical Pharmacy Practice and Policy Research in the Middle East and the GCC Region: Evidence, Impact, Implementation and the way forward
Deadline 2027-05-31Taylor & FrancisIndexed (Active)
Journal: Journal of Pharmaceutical Policy and Practice
Clinical pharmacy practice and policy research in the Middle East and Gulf Cooperation Council (GCC) countries is rapidly advancing towards a patient-centered care model. Key priorities include optimizing medication use and enhancing pharmaceutical care services. Health systems in the region are evolving, with technology and artificial intelligence expected to play an increasingly significant role in clinical pharma…
Special Series in the Journal of Pharmaceutical Policy and Practice – 50th Anniversary of the WHO Model List of Essential Medicines
Deadline 2027-12-31Taylor & FrancisIndexed (Active)
Journal: Journal of Pharmaceutical Policy and Practice
2027 marks the 50 th anniversary of the World Health Organization Model List of Essential Medicines. In 1977, the World Health Organization published the first list of 205 items and 186 medicines with the goal to support countries in their “selection and procurement, at reasonable cost, of essential drugs of established quality corresponding to their national health needs”. The concept of essential medicines is wide…
Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.
DrAIStudio